F2RL1-DuET Citations (1)

Originally described in: Multiplexed selectivity screening of anti-GPCR antibodies.
Dahl L, Kotliar IB, Bendes A, Dodig-Crnkovic T, Fromm S, Elofsson A, Uhlen M, Sakmar TP, Schwenk JM Sci Adv. 2023 May 3;9(18):eadf9297. doi: 10.1126/sciadv.adf9297. Epub 2023 May 3. PubMed Journal

---

Articles Citing F2RL1-DuET

Articles

Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapy. Aouad S, Kadiri M, Allard D, Skora E, Giraud L, Fuselier C, Desroys du Roure P, Mousson A, Janvier A, Baron L, Franchet C, Lecru L, Routy B, Malo J, Brugat T, Blayo AL, Schann S, Stagg J. J Immunother Cancer. 2026 Apr 3;14(4):e013507. doi: 10.1136/jitc-2025-013507. PubMed

If you have published an article using this material, please email us at to have your article added to this page.